75 related articles for article (PubMed ID: 19540617)
1. Long-term stability and circadian variation in circulating levels of surfactant protein D.
Hoegh SV; Sorensen GL; Tornoe I; Lottenburger T; Ytting H; Nielsen HJ; Junker P; Holmskov U
Immunobiology; 2010 Apr; 215(4):314-20. PubMed ID: 19540617
[TBL] [Abstract][Full Text] [Related]
2. Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study.
Hoegh SV; Lindegaard HM; Sorensen GL; Høj A; Bendixen C; Junker P; Holmskov U
Scand J Immunol; 2008 Jan; 67(1):71-6. PubMed ID: 18052966
[TBL] [Abstract][Full Text] [Related]
3. Circulating surfactant protein D is decreased in systemic lupus erythematosus.
Hoegh SV; Voss A; Sorensen GL; Høj A; Bendixen C; Junker P; Holmskov U
J Rheumatol; 2009 Nov; 36(11):2449-53. PubMed ID: 19833760
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of surfactant protein D in horses with lower airway inflammation.
Richard EA; Pitel PH; Christmann U; Lekeux P; Fortier G; Pronost S
Equine Vet J; 2012 May; 44(3):277-81. PubMed ID: 21696440
[TBL] [Abstract][Full Text] [Related]
5. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker.
Glas J; Beynon V; Bachstein B; Steckenbiller J; Manolis V; Euba A; Müller-Myhsok B; Folwaczny M
Tissue Antigens; 2008 Jul; 72(1):21-8. PubMed ID: 18498293
[TBL] [Abstract][Full Text] [Related]
7. Serum surfactant protein D is elevated in allergic patients.
Koopmans JG; van der Zee JS; Krop EJ; Lopuhaä CE; Jansen HM; Batenburg JJ
Clin Exp Allergy; 2004 Dec; 34(12):1827-33. PubMed ID: 15663555
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS.
Endo S; Sato N; Nakae H; Yamada Y; Makabe H; Abe H; Imai S; Wakabayashi G; Inada K; Sato S
Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):245-51. PubMed ID: 15244040
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein D in human lung diseases.
Hartl D; Griese M
Eur J Clin Invest; 2006 Jun; 36(6):423-35. PubMed ID: 16684127
[TBL] [Abstract][Full Text] [Related]
10. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.
Hill J; Heslop C; Man SF; Frohlich J; Connett JE; Anthonisen NR; Wise RA; Tashkin DP; Sin DD
Eur Heart J; 2011 Aug; 32(15):1918-25. PubMed ID: 21653561
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis.
Christensen AF; Hoegh SV; Lottenburger T; Holmskov U; Tornoe I; Hørslev-Petersen K; Sørensen GL; Junker P
Rheumatol Int; 2011 Dec; 31(12):1617-23. PubMed ID: 20512337
[TBL] [Abstract][Full Text] [Related]
12. Plasma surfactant D in patients following acute paraquat intoxication.
Gil HW; Hong JR; Park JH; Seo YS; Yang JO; Lee EY; Hong SY
Clin Toxicol (Phila); 2007; 45(5):463-7. PubMed ID: 17503247
[TBL] [Abstract][Full Text] [Related]
13. Serum surfactant protein D is increased in acute and chronic inflammation in mice.
Fujita M; Shannon JM; Ouchi H; Voelker DR; Nakanishi Y; Mason RJ
Cytokine; 2005 Jul; 31(1):25-33. PubMed ID: 15967375
[TBL] [Abstract][Full Text] [Related]
14. Postmortem serum levels of pulmonary surfactant-associated proteins A and D with regard to the cause of death in medicolegal autopsy.
Quan L; Zhu BL; Ishikawa T; Michiue T; Zhao D; Yoshida C; Chen JH; Wang Q; Komatsu A; Azuma Y; Maeda H
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S301-3. PubMed ID: 19254864
[TBL] [Abstract][Full Text] [Related]
15. An enzyme-linked immunosorbent assay (ELISA) for quantification of mouse surfactant protein D (SP-D).
Hansen S; Schmidt V; Steffensen MA; Jensen PH; Gjerstorff M; Thiel S; Holmskov U
J Immunol Methods; 2008 Jan; 330(1-2):75-85. PubMed ID: 18078951
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
18. In defense of the lung: surfactant protein A and surfactant protein D.
Kingma PS; Whitsett JA
Curr Opin Pharmacol; 2006 Jun; 6(3):277-83. PubMed ID: 16580255
[TBL] [Abstract][Full Text] [Related]
19. Circulating surfactant protein D is associated to mortality in elderly women: a twin study.
Wulf-Johansson H; Thinggaard M; Tan Q; Johansson SL; Schlosser A; Christensen K; Holmskov U; Sorensen GL
Immunobiology; 2013 May; 218(5):712-7. PubMed ID: 22999473
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages.
Ferguson JS; Voelker DR; McCormack FX; Schlesinger LS
J Immunol; 1999 Jul; 163(1):312-21. PubMed ID: 10384130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
